Loss of ARID1A in gastric cancer is correlated with advanced stage, tumour invasion, lymphovascular invasion, lymph node metastases, and reduced survival [77,79,80,81,82,83], especially in poorly differentiated and early-stage cases [83]. Here, ARID1A is linked to neoplasm.